Skip to main content

Clinical and Translational Oncology

Ausgabe 2/2024

Inhalt (26 Artikel)

Open Access A SYSTEMATIC REVIEW

Glioblastoma research on zebrafish xenograft models: a systematic review

Alexandra Pliakopanou, Ilias Antonopoulos, Nikolia Darzenta, Iliana Serifi, Yannis Vasilios Simos, Andreas Panagiotis Katsenos, Stefanos Bellos, George Athanasios Alexiou, Athanasios Petros Kyritsis, Ioannis Leonardos, Patra Vezyraki, Dimitrios Peschos, Konstantinos Ioannis Tsamis

REVIEW ARTICLE

Mechanism of action and treatment of type I interferon in hepatocellular carcinoma

Chunxiu Peng, Zhijian Ye, Ying Ju, Xiuxin Huang, Chenjie Zhan, Ke Wei, Zhiyong Zhang

REVIEW ARTICLE

Energy metabolism: a new target for gastric cancer treatment

Jiangrong Liu, Xue Bai, Meilan Zhang, Shihua Wu, Juan Xiao, Xuemei Zeng, Yuwei Li, Zhiwei Zhang

SPECIAL ARTICLE

The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium

Nuria Viñolas, Laura Mezquita, Jesús Corral, Manuel Cobo, Francisco Gil-Moncayo, Luis Paz-Ares, Jordi Remon, María Rodríguez, Alberto Ruano-Raviña, Esther Conde, Margarita Majem, Pilar Garrido, Enriqueta Felip, Dolores Isla, Javier de Castro

RESEARCH ARTICLE

MicroRNA-128 acts as a suppressor in the progression of gastrointestinal stromal tumor by targeting B-lymphoma Mo-MLV insertion region 1

Jinbao Wu, Changjuan Wang, Xia Cui, Lin Liu, Lu Wang, Jing Wang, Xiaohui Xue, Tong Dang

RESEARCH ARTICLE

A nomogram based on 4-lncRNAs signature for improving prognostic prediction of hepatocellular carcinoma

Qingguo Mo, Wenjing Li, Lin Liu, Zhidong Hao, Shengjun Jia, Yongsheng Duo

Research Article

Prognostic model of ER-positive, HER2-negative breast cancer predicted by clinically relevant indicators

Xinming Song, Pintian Wang, Ruiling Feng, Mandika Chetry, E. Li, Xiaohua Wu, Zewa Liu, Shasha Liao, Jing Lin

RESEARCH ARTICLE

Surface guided radiation therapy with an innovative open-face mask and mouth bite: patient motion management in brain stereotactic radiotherapy

Xuemei Chen, Lu Liu, Yajuan Wang, Xiaotong Huang, Weixun Cai, Xiaodong Rong, Liuwen Lin, Jindi Liu, Xiaobo Jiang

Open Access RESEARCH ARTICLE

Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era

Xiaohong Xie, Guihuan Qiu, Ziyao Chen, Ting Liu, Yilin Yang, Zhixuan You, Chen Zeng, Xinqing Lin, Zhanhong Xie, Yinyin Qin, Yansheng Wang, Xiaodong Ma, Chengzhi Zhou, Ming Liu

RESEARCH ARTICLE

Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival

Yaxiong Tang, Lede Lin, Yunfei Xiao, Linghao Meng, Yujia Yang, Xiang Li

Research Article

Status of head and neck brachytherapy in Spain in 2022

Jose Luis Guinot, Patricia Diezhandino, Jesus Maria de Frutos, Naiara Fuentemilla, Victor Gonzalez-Perez, Cristina Gutierrez, Antonio Herreros, Rafael Martinez-Monge, Susana Perez-Echagüen, Francisco Pino, Susana Roldán, Angels Rovirosa, Miguel Angel Santos, Camilo Jose Sanz-Freire, Elena Villafranca

RESEARCH ARTICLE

Bone metastatic cancer of unknown primary at initial presentation

Masatake Matsuoka, Tomohiro Onodera, Isao Yokota, Koji Iwasaki, Yuki Suzuki, Hamasaki Masanari, Eiji Kondo, Norimasa Iwasaki

Open Access RESEARCH ARTICLE

Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis

Fengxiang Huang, Haiyan Yang, Wenguang Bao, Yehong Bin, Shengsheng Zhou, Man Wang, Xiaoping Lv

RESEARCH ARTICLE

A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer

Xi Chen, Chunyan Liao, Xiong Zou, Bei Zhang, Zengnan Mo

RESEARCH ARTICLE

Prognostic value of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: a meta-analysis

Chengkun Yan, Yanyou Xie, Yaqi Hua, Sihui Li, Huanxu Fu, Zhiqiang Cheng, Jiehua Wu

RESEARCH ARTICLE

Is surgical indication in multiple myeloma a poor prognosis sign? SEER database analysis

Recep Öztürk, Kamil Amer, Ayşe Tuğçenur Gençoğlu, Fatma Gökçenur Öztürk, Kamber Kasali, Mahmut Nedim Aytekin

RESEARCH ARTICLE

Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors

Álvaro Pinto, Jesús Miranda, Ana Pertejo, Mario Álvarez-Maestro, Pilar González-Peramato, Alfredo Aguilera, Eugenia García, Lucía Trilla, Ángelo Gámez, Enrique Espinosa

RESEARCH ARTICLE

Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience

Marina Serrano, Nerea Muñoz-Unceta, Lucía Andrea Alonso, Ainara Azueta, José Luis Gutiérrez Baños, Laura Ferreira, Mario Domínguez, Albero Torres Zurita, Roberto Ballestero, Diego Cacho, Marta López-Brea, Marta Sotelo, Félix Campos-Juanatey, Enrique Ramos Barseló, Ignacio Duran

Correction

Correction to: Efficacy and safety of trifluridine/tipiracil (TAS‑102) in patients with metastatic colorectal cancer: a systematic review and meta‑analysis

Fengxiang Huang, Haiyan Yang, Wenguang Bao, Yehong Bin, Shengsheng Zhou, Man Wang, Xiaoping Lv

Open Access Correction

Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori, Lucía González Cortijo, Fernando Henao Carrasco, María Teresa Martínez Martínez, Cristina Morales Estévez, Agostina Stradella, María Jesús Vidal Losada, Eva Ciruelos

Correction

Correction to: Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors

Chang Liu, Zhenxing Wang, Qian Liu, Guangyao Wu, Chunhong Chu, Lanxin Li, Lei An, Shaofeng Duan

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.